Possible Aspergillus Contamination Prompts Recall Of Curaleaf Product

marijuana

An Arizona marijuana establishment is voluntarily recalling Curaleaf MnC batch number MnC-IC123H2-N due to possible contamination with Aspergillus.

The Arizona Department of Health Services (ADHS) is advising purchasers to dispose of the products, which ADHS was made aware of by a marijuana establishment.

To date, no illnesses have been reported. The announcement is being made “out of an abundance of caution,” according to ADHS.

ADHS says patients who have purchased potentially contaminated products should not ingest, inhale, or otherwise consume them and should dispose of them. If you have already consumed any of the products and have any of the symptoms described below, you are advised to contact your health care provider or seek care in the event of an emergency.

ADHS was made aware of the possible contaminated product by the marijuana establishment that sold the product.

Once ADHS discovered the potential contamination, it contacted the facility that produced the products.

Curaleaf issued the following statement:

On October 10, 2023, Curaleaf management was alerted to a failing test result for Find Flower “Mac N Cheese” Batch No. MNC-C1-230301 and immediately pulled the product from shelves. Following an internal investigation, it was discovered that the original test result failed for aspergillus and the batch was released from production quarantine due to an unintentional human error. Internal disciplinary action was taken and the directly responsible team member has been removed from the production area. 

On October 14, 2023, a second re-test confirmed the original failing result, leading to a voluntary product recall. The Company self-reported to the Arizona Department of Health Services (AZDHS) to inform them of the matter and ensure appropriate action is taken, including alerting all customers impacted.

Curaleaf accepts full responsibility and apologizes to our Arizona patients and customers for this inconvenience. Patient and customer safety and satisfaction are our number one priority, and we are immediately evaluating our revised quality control practices to correct any gaps and prevent this mistake from occurring again. Curaleaf is grateful to the ADZHS for their continued partnership as this process demonstrates the integrity of the legal cannabis market.

Patients who have concerns about any of our products are encouraged to email us at Info.AZ@Curaleaf.com

Editor’s Note: This article has been updated to include Curaleaf’s statement 10/23/2023.

About ADI Staff Reporter 12345 Articles
Under the leadership of Editor-in -Chief Huey Freeman, our team of staff reporters bring accurate,timely, and complete news coverage.